Showing results (21-30 of 215) with videos related to
Sort By:
Pageof 22
Diagnostic Microbiology and Infectious Disease|March 16, 2010
Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolatesAndrew Walkty, David A Boyd, Denise Gravel, et al.Scandinavian Journal of Infectious Diseases|July 27, 2007
Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinamLindsay E Nicolle, Michael R MulveyThe Journal of Antimicrobial Chemotherapy|December 23, 2017
Characterization of OXA-48-like carbapenemase producers in Canada, 2011-14Laura F Mataseje, David A Boyd, Jeffrey Fuller, et al.Msphere|May 20, 2021
Emergence of Morganellaceae Harboring blaIMP-27 Metalloenzyme in CanadaDavid A Boyd, Laura F Mataseje, Tanis Dingle, et al.Journal of Infection in Developing Countries|March 2, 2016
New Delhi metallo-β-lactamase in JamaicaCamille-Ann Thoms-Rodriguez, Tony Mazzulli, Nicole Christian, et al.Emerging Infectious Diseases|March 31, 2010
Hypervirulent Clostridium difficile strains in hospitalized patients, CanadaMichael R Mulvey, David A Boyd, Denise Gravel, et al.Military Medicine|January 14, 2005
Unilateral lower extremity edema in May-Thurner syndromeDavid A BoydMicrobial Drug Resistance (Larchmont, N.Y.)|February 21, 2023
Genetic and Phenotypic Characterization of the First Canadian Case of Ambler Class A Carbapenemase FRI-8Laura F Mataseje, Florence Doualla-Bell, David A Boyd, et al.Antimicrobial Agents and Chemotherapy|February 23, 2017
Enterobacter cloacae Complex Isolates Harboring blaNMC-A or blaIMI-Type Class A Carbapenemase Genes on Novel Chromosomal Integrative Elements and PlasmidsDavid A Boyd, Laura F Mataseje, Ross Davidson, et al.Antimicrobial Agents and Chemotherapy|May 20, 2015
Effect of Variants of Penicillin-Binding Protein 2 on Cephalosporin and Carbapenem Susceptibilities in Neisseria gonorrhoeaeAmrita Bharat, Walter Demczuk, Irene Martin, et al.Pageof 22